From: Inhibitor clinical burden of disease: a comparative analysis of the CHESS data
Outcomes | Patients who never developed inhibitors | Patients with current inhibitors | p-valueb |
---|---|---|---|
N = 58 | N = 58 | ||
Bleeds in the past 12 months (major and minor bleeds) | |||
Mean ± SD | 3.72 ± 3.95 | 8.29 ± 9.18 | <.0001 |
Median (range) | 3 (0.00–18.00) | 6 (1.00–60.00) | |
Major bleeds, N (%) | |||
Yes | 22 (37.9) | 47 (81.0) | <.0001 |
No | 36 (62.1) | 11 (19.0) | |
Minor bleeds, N (%) | |||
Yes | 48 (82.8) | 58 (100.0) | .0047 |
No | 10 (17.2) | 0 (0.0) | |
Joint bleeds in past 12 months | |||
Mean ± SD | 0.98 ± 1.15 | 2.17 ± 1.90 | <.0001 |
Median (range) | 1 (0.00–4.00) | 2 (0.00–8.00) | |
Yes, N (%) | 32 (55.2) | 54 (93.1) | <.0001 |
No, N (%) | 26 (44.8) | 4 (6.9) |